GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » Market Cap

Whanin Pharm Co (XKRX:016580) Market Cap : ₩179,083 Mil (As of Apr. 22, 2025)


View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Whanin Pharm Co's share price for the quarter that ended in Dec. 2024 was ₩11810. Whanin Pharm Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 15 Mil. Therefore, Whanin Pharm Co's market cap for the quarter that ended in Dec. 2024 was ₩180,303 Mil.

Whanin Pharm Co's quarterly market cap declined from Jun. 2024 (₩220,913 Mil) to Sep. 2024 (₩203,967 Mil) and declined from Sep. 2024 (₩203,967 Mil) to Dec. 2024 (₩180,303 Mil).

Whanin Pharm Co's annual market cap declined from Dec. 2022 (₩268,699 Mil) to Dec. 2023 (₩229,616 Mil) and declined from Dec. 2023 (₩229,616 Mil) to Dec. 2024 (₩180,303 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Whanin Pharm Co's Enterprise Value for Today is ₩126,915 Mil.


Whanin Pharm Co Market Cap Historical Data

The historical data trend for Whanin Pharm Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whanin Pharm Co Market Cap Chart

Whanin Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 254,958.90 271,752.60 268,699.20 229,615.68 180,303.27

Whanin Pharm Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 229,615.68 221,982.18 220,913.49 203,967.12 180,303.27

Competitive Comparison of Whanin Pharm Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Whanin Pharm Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Whanin Pharm Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Whanin Pharm Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Whanin Pharm Co's Market Cap falls into.


;
;

Whanin Pharm Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Whanin Pharm Co's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=₩11810*15.267
=₩180,303

Whanin Pharm Co's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=₩11810*15.267
=₩180,303

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Whanin Pharm Co  (XKRX:016580) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Whanin Pharm Co Market Cap Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Whanin Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200
Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co Headlines

No Headlines